FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Allows Cook Medical Pediatric Esophageal Device on Market

FDA authorizes the use of Cook Medicals Flourish Pediatric Esophageal Atresia Anastomosis, a device to treat infants up to one year old for a birth de...

FDA General

Trump Budget for FDA a Non-starter: Alliance

Holding some hope for a Trump Administration change of heart, the Alliance for a Stronger FDA calls its proposed 37% FDA budget cut in 2018 a non-star...

Human Drugs

Orphan Drug Status for Loxo Oncology Tumor Drug

FDA grants Loxo Oncology an orphan drug designation for larotrectinib for treating solid tumors with NTRK-fusion proteins, which are genetic abnormali...

Human Drugs

AstraZeneca Sees Positive Results from Imfinzi in Lung Cancer

AstraZeneca and MedImmune announce positive results from their Phase 3 PACIFIC trial, a randomized, double-blinded, placebo-controlled trial of Imfinz...

Human Drugs

Alzheimers Researchers Want Revised Drug Approval Standard

Alzheimers disease researchers urge FDA to clarify and modernize its current approach for approving new treatments for Alzheimers.

Human Drugs

Exact-Rx Cleanser Label Inaccurate: FDA

FDA says Exact-Rx must correct deficiencies in the listing for its Sulfacetamide and Sulfer Cleanser.

Human Drugs

Appeals Court Affirms Genentech Whistleblower Case Dismissal

Attorney Armandeep Sindhu says the 3rd Circuit Appeals Court affirmed a lower court ruling dismissing a whistleblower case against Genentech over its ...

Human Drugs

FDA Releases Biocon Inspection 483

FDA releases the FDA-483 with eight inspection observations from a recent inspection at Indias Biocon Limited.

Human Drugs

3 Early Cures Act Priorities for Gottlieb

Two Epstein Becker Green attorneys say new FDA commissioner Scott Gottlieb is likely to meet three coming 21st Century Cures Act deadlines.

Human Drugs

Coherus Biosciences Wants Apotex Neulasta Petition Denied

Coherus Biosciences asks FDA to deny an Apotex petition on a Neulasta biosimilar because it contains erroneous information on the role of clinical tri...